Adaptimmune in ‘vein-to-vein’ deal with Cryoport’s SmartPak 15-Oct-2019 By Vassia Barba Adaptimmune adopts Cryoport’s SmartPak logistic services for shipment of its oncology T-cell therapy candidates, under a three-year agreement.